Tag: Prescription Drugs
Retail Prescription Drug Prices Fall for First Time in 45 Years
Decrease due to drops in generic drug prices and slow growth in the cost of brand-name medications
FDA Testing Levels of Carcinogen in Diabetes Drug Metformin
No metformin recalls affect U.S. market at the moment
First-Line Osimertinib May Up Survival in EGFR-Mutated NSCLC
For previously untreated disease, overall survival longer with osimertinib versus comparator EGFR-TKIs
Ubrogepant Relieves Pain, Symptoms of Acute Migraine
More patients receiving ubrogepant 50 mg, 100 mg versus placebo report freedom from pain at two hours
New HIV Infections Remained Stable in U.S. From 2013 to 2017
Of the 1.2 million people with indications for PrEP in 2018, only 18.1 percent had been prescribed PrEP
New Federal Program Provides Free HIV Prevention Drugs to Uninsured
Expanding access to PrEP is key part of government's aim of ending nation's HIV epidemic by 2030
Obesity Mediates Response to Antiarrhythmic Drugs in A-Fib
Reduced response to sodium versus potassium channel blocker AADs seen in obese patients, mice
U.S. Adults With ASCVD Report Skipping Meds Due to Costs
Age <65 years, female sex, high comorbidity burden independently linked to cost-related nonadherence
Three Meds Equal as Second-Line Therapy for Status Epilepticus
Levetiracetam, fosphenytoin, valproate treat seizures unresponsive to benzodiazepine in children, adults
Taking Multiple Fracture-Linked Meds Ups Risk for Hip Fracture
Addition of second and third fracture-associated drugs linked to increased risk for women and men
